Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.74 USD | +3.57% | -5.95% | -22.67% |
05-13 | Oppenheimer Adjusts Vor Biopharma Price Target to $10 From $15, Maintains Outperform Rating | MT |
05-09 | Vor Biopharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
115M | - | - | - | - | - | |
49.18B | - | |||||
42.11B | ||||||
40.37B | ||||||
28.85B | ||||||
26.09B |
- Stock Market
- Equities
- VOR Stock
- Charts Vor Biopharma Inc.
- Sector Chart